Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
Year: 2019
Type: review
Abstract: New treatments for multiple sclerosis (MS) focused on B cells have created an atmosphere of excitement in the MS community. B cells are now known to play a major role in disease, demonstrated by the highly impactful effect of a B cell-depleting antibody on controlling MS. The idea that a virus may play a role in the development of MS has a long history and is supported mostly by studies demonstrating a link between B cell-tropic Epstein-Barr virus (EBV) and disease onset. Efforts to develop antiviral strategies for treating MS are underway. Although gaps remain in our understanding of the etiology of MS, the role, if any, of viruses in propagating pathogenic immune responses deserves attention.
Source: Trends in Molecular Medicine
Institutions: University of Pennsylvania, The University of Queensland, QIMR Berghofer Medical Research Institute, Stanford Medicine, Stanford University, Heinrich Heine University Düsseldorf, Torque (United States), Incorporated Research Institutions For Seismology, Atara Biotherapeutics (United States), Queen Mary University of London, Blizard Institute
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,000
OpenAlex ID: W2994779767
